Prevymis (letermovir) - Merck (MSD)
cyclophosphamide - Generic mfg.
Letermovir prophylaxis for cytomegalovirus infection in hematopoietic transplantation with post-transplant cyclophosphamide. (PubMed, Medicina (B Aires)) - Jun 27, 2025 - "In summary, letermovir effectively prevented CMV infection in this high-risk population of allo-HCT recipients." 
Journal • Retrospective data • Bone Marrow Transplantation • Cytomegalovirus Infection • Graft versus Host Disease • Immunology • Infectious Disease • Transplantation
http://www.ncbi.nlm.nih.gov/pubmed/40577139
 
Adriana V Vitriu; Georgina Bendek; Gonzalo Bentolila; Jorge Arbelbide; Juliana Martinez Rolon; Karla Oliveros; Lucia Fuente; Luis E Ayala; María Cecilia Foncuberta; Mariano Berro; Martin Castro; Melina Garbarini; Milagros Szelagowski; Olivia Gelo
 
Jun 27, 2025
 
Prev Next